Dimethyladenosine transferase 1, mitochondrial (TFB1M) is a mitochondrial methyltransferase essential for mitochondrial gene expression. It catalyzes the dimethylation of two adjacent adenosine residues in the loop of helix 45 at the 3′ end of mitochondrial 12S rRNA, using S-adenosylmethionine as a methyl donor. This rRNA modification is highly conserved and crucial for the biogenesis and stability of the mitochondrial small ribosomal subunit, thereby facilitating mitochondrial protein synthesis. TFB1M has been implicated in basal mitochondrial transcription in vitro, though its main role is as a methyltransferase; its close paralog TFB2M serves as the primary mitochondrial transcription factor. Mutations or polymorphisms in TFB1M are associated with increased risk of maternally inherited deafness, aminoglycoside antibiotic-induced ototoxicity, and potentially type II diabetes, underlining its importance in mitochondrial health and disease.
Other names
Transcription factor B1, mitochondrialCGI-75h-mtTFBh-mtTFB1hTFB1MmtTFB1mtTFBmitochondrial 12S rRNA dimethylase 1S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1homolog of yeast mitochondrial transcription factor B
02
Mechanism of action
Methylation of mitochondrial 12S rRNA, a necessary modification for mitochondrial protein synthesis and ribosome assembly.
03
Biological functions
Dimethylation of 12S mitochondrial rRNA: Catalyzes dimethylation of two adjacent adenosine residues (A1583 and A1584) in the stem-loop near the 3'-end of mitochondrial 12S rRNA, which is critical for assembly or stability of the small mitoribosomal subunitRegulation of mitochondrial ribosome biogenesis: Essential for mitochondrial ribosomal function and protein synthesisComponent of the mitochondrial transcriptional machinery: Implicated in basal mitochondrial transcription, although this role is less prominent than its paralog TFB2M
04
Disease associations
Deafness (especially aminoglycoside-induced and maternally inherited forms)Type II diabetes mellitus (risk factor through specific polymorphisms)Mitochondrial dysfunction-related disorders
05
Safety considerations
Alteration in TFB1M activity or mutations can lead to mitochondrial dysfunction, maternal pattern hearing loss, increased aminoglycoside sensitivity, and potentially contribute to diabetes susceptibilityOff-target inhibition risks: Since TFB1M is essential for mitochondrial function, inhibition could impair cellular energy metabolism, posing a risk of toxicity
06
Biomarkers
Mitochondrial 12S rRNA methylation pattern (as a potential research biomarker for certain mitochondrial diseases and aminoglycoside-induced toxicity, not established in clinical practice)Presence of specific TFB1M polymorphisms may be associated with risk prediction for aminoglycoside-induced deafness and diabetes
Beyond the preview
Go deeper on Dimethyladenosine transferase 1, mitochondrial (TFB1M).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dimethyladenosine transferase 1, mitochondrial (TFB1M).